Enweghị ike imebi nchekwa nri, yana ahụike mmadụ kwesịrị ichebe oge niile.

Xiamen Changsu Industrial Co., Ltd., onye enyemaka nke Sinolong Group, emeela ọganihu teknụzụ dị egwu n'oge na-adịbeghị anya site n'ịmepụta ihe nkiri BOPA antibacterial na-eme nke ọma na ọkwa nnwale na nzaghachi na mmetọ nke microorganisms pathogenic na usoro nkesa nri.

BOPA antibacterial ejirila SGS kwadoro.Dị ka akụkọ nyocha si kwuo, arụmọrụ antibacterial nke BOPA dị mma megide G+ na G-Escherichia coli na Staphylococcus aureus nkịtị, yana ọnụ ọgụgụ nje bacteria karịa 99.9%.

Usoro nke antimicrobial BOPA bụ na mgbe onye na-ahụ maka nje na-abanye na kọntaktị na microorganisms, ọ na-adabere na Coulombattraction na-eme ka onye na-ahụ maka antimicrobial kwadoro ya na mkpụrụ ndụ microorganism, nke na-emebi nguzozi electrolyte ha, si otú a na-eme ka e gbuo microorganism n'ihi mmebi nke mgbidi cell, n'ikpeazụ na-eweta nchebe karịa ndị na-azụ ahịa.

Ugbu a, a ka nwere ohere n'ahịa zuru ụwa ọnụ maka BOPA antibacterial.Ọ bụrụ na ngwaahịa ahụ enweta ọtụtụ mmepụta ihe, ọ ga-enwe ngwa ngwa dị iche iche na nkwakọ nri dị ka nri ọhụrụ, ngwaahịa mmiri na mpaghara oyi oyi, yana nkwakọ ngwaahịa maka ngwaahịa na-eji kwa ụbọchị na nkwakọ ngwaahịa maka ụlọ ọrụ ọgwụ.Karịsịa n'okpuru ndabere nke mgbasa COVID-19 na-agbasa na ugboro ugboro yana mkpa nchekwa nri na-abawanye, BOPA antibacterial ga-enye ohere ọhụrụ maka ngwọta nkwakọ ngwaahịa dị mma maka ụlọ ọrụ nri.

Na nzọụkwụ na-esote, Xiamen Changsu ga-agbaso nkà na ụzụ na mmepụta ihe ọhụrụ, na-aga n'ihu na-abawanye mgbalị R & D, jikọọ aka na ndị mmekọ ndị ọzọ iji weta BOPA antibacterial n'ahịa ngwa ngwa o kwere mee, na-eji nkà na ụzụ eme ihe iji mee ka nkwalite nke ọrụ nkwakọ ngwaahịa na-agbanwe agbanwe. ma mepee isiakwụkwọ ọhụrụ maka nchekwa nri.